Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KENNETH CUSI

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1770690752
CMS profile
1239301
Location
GAINESVILLE, FL

General Payments · PY2018–2024

$261,051.07

  • Reported across 173 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$44,432.37

25 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $15,045.28 12
Novo Nordisk AS $8,595.14 2
GlaxoSmithKline, LLC. $7,800.00 2
DEXCOM, INC. $5,950.00 4
Zealand Pharma A/S $3,709.68 2
Novo Nordisk AS $3,332.27 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $29,350.78 26
PY2019 $72,991.19 50
PY2020 $32,624.24 17
PY2021 $24,095.00 11
PY2022 $19,154.26 11
PY2023 $38,403.23 33
PY2024 $44,432.37 25

Payment records · PY2024 (25)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boehringer Ingelheim Pharmaceuticals, Inc. $692.91 09/12/2024 Travel and Lodging Undisputed 01/23/2026 1118148742 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $166.25 09/26/2024 Travel and Lodging Undisputed 01/23/2026 1118148736 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $227.75 09/26/2024 Travel and Lodging Undisputed 01/23/2026 1118148738 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 11/12/2024 Food and Beverage Undisputed 01/23/2026 1118148722 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 11/12/2024 Travel and Lodging Undisputed 01/23/2026 1118148734 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13,175.00 11/12/2024 Consulting Fee Undisputed 01/23/2026 1118148744 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $40.16 11/19/2024 Food and Beverage Undisputed 01/23/2026 1118148724 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $45.90 11/19/2024 Food and Beverage Undisputed 01/23/2026 1118148726 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $45.90 11/19/2024 Food and Beverage Undisputed 01/23/2026 1118148728 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $49.95 11/19/2024 Food and Beverage Undisputed 01/23/2026 1118148730 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $138.24 11/19/2024 Food and Beverage Undisputed 01/23/2026 1118148732 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $288.22 11/19/2024 Travel and Lodging Undisputed 01/23/2026 1118148740 CMS
Dexcom, Inc. $1,785.00 03/19/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1153313868 CMS
Dexcom, Inc. $595.00 04/16/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1153313870 CMS
Dexcom, Inc. $2,975.00 07/23/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1153313866 CMS
Dexcom, Inc. $595.00 08/06/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1153313872 CMS
GlaxoSmithKline, LLC. $7,150.00 01/09/2024 Consulting Fee Undisputed 01/23/2026 1116022110 CMS
GlaxoSmithKline, LLC. $650.00 06/17/2024 Consulting Fee Undisputed 01/23/2026 1116678997 CMS
Novo Nordisk AS $45.14 06/06/2024 Food and Beverage Undisputed 01/23/2026 1096552227 CMS
Novo Nordisk AS $8,550.00 06/06/2024 Consulting Fee Undisputed 01/23/2026 1096552333 CMS
Novo Nordisk Inc $2,100.00 01/03/2024 Consulting Fee Undisputed 01/23/2026 1097838510 CMS
Novo Nordisk Inc $32.27 09/06/2024 Education Undisputed 01/23/2026 1097405940 CMS
Novo Nordisk Inc $1,200.00 09/09/2024 Consulting Fee Undisputed 01/23/2026 1096960275 CMS
Zealand Pharma A/S $3,600.00 07/16/2024 Consulting Fee Undisputed 01/23/2026 1141363237 CMS
Zealand Pharma A/S $109.68 08/01/2024 Food and Beverage Undisputed 01/23/2026 1141363233 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.